Southeast Life Sciences, the organization behind 400 presentations, 790 funding transactions, and $5.2B in investments from 500 distinct investors is going virtual for a special edition of PitchRounds.

As the nation and globe battle Covid-19, innovators and early stage companies continue to attempt to address the worst pandemic in a century. In some cases they are, or will need to, pivot to position themselves to succeed as the industry including early stage investors adjusts.

The week of June 16 we will host a special PitchRounds competition for early-stage southeastern companies working on Covid-19 products. We are accepting applications until May 22 through the F6S application. We encourage southeast-based early stage medtech and life science companies in any aspect of healthcare – diagnostics, treatments, vaccines, telehealth technologies, devices and even hygienics and PPE to apply.

The inaugural virtual event will follow the same format as our in-person PitchRounds events. Selected companies will make 10-minute presentations followed by Q&A from our investor panel.